drugset / Trial / NCT07642674

The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain

NCT07642674

Recruiting 66 enrolled Eskisehir Osmangazi University
RandomizedCrossoverSingle-blindPrevention

Summary

Orthopedic shoulder surgeries are associated with severe postoperative pain, particularly within the first 24-48 hours after surgery. In postoperative pain management, single or continue interscalene brachial plexus blocks, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids administered as needed are commonly used as components of multimodal analgesia. Rebound pain is defined as severe postoperative pain (VAS ≥ 7) occurring within the first 24 hours after resolution of the block. It is considered an adverse effect of regional anesthesia and typically develops 8-12 hours after a single-shot nerve block. Risk factors for rebound pain include pre-existing pain, female sex, younger age, bone surgery, lack of intraoperative dexamethasone administration, and inadequate analgesia. The primary objective of this study is to evaluate the effect of intravenous dexketoprofen administered during the postoperative period on the incidence and severity of rebound pain in patients undergoing shoulder surgery with interscalene brachial plexus block

Timeline

Start
2026-06-11
Primary completion
2027-01-01
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexketoprofen Small molecule 25 mg Intravenous
Comparator Acetaminophen Small molecule 1 g Intravenous

Indications

No indication recorded.